Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infections

• Published in: Infectious diseases & immunity (Online) Vol. 2; no. 3; pp. 168 - 178
• Main Authors: Ning, Qin, Chen, Tao, Wang, Guiqiang, Xu, Dong, Yu, Yanyan, Mao, Qing, Li, Taisheng, Li, Lanjuan, Li, Jun, Lu, Xiaoju, Li, Jiabin, Li, Zhiwei, Zhang, Wenhong, Xiao, Yonghong, Meng, Qinghua, Mi, Yuqiang, Shang, Jia, Yu, Yunsong, Zhao, Yingren, Zhao, Caiyan, Zhao, Hong, Huang, Jianrong, Peng, Jie, Tang, Hong, Tang, Xiaoping, Hu, Jinhua, Hu, Bijie, Guo, Wei, Zheng, Bo, Chen, Baiyi, Zhang, Yuexin, Wei, Jia, Sheng, Jifang, Chen, Zhi, Wang, Minggui, Xie, Qing, Wang, Yuming, Wang, Fu-Sheng, Hou, Jinlin, Duan, Zhongping, Wei, Lai, Jia, Jidong
• Format: Journal Article
• Language: English
• Published: Wolters Kluwer Health - Lippincott Williams Wilkins 01-07-2022
• ISSN: 2693-8839; 2693-8839
• DOI: 10.1097/ID9.0000000000000055

Abstract End-stage liver disease (ESLD) is a life-threatening clinical syndrome that markedly increases mortality in patients with infections. In patients with ESLD, infections can induce or aggravate the occurrence of liver decompensation. Consequently, infections are among the most common complications of disease progression. There is a lack of working procedure for early diagnosis and appropriate management for patients with ESLD complicated by infections as well as local and international guidelines or consensus. This consensus assembled up-to-date knowledge and experience across Chinese colleagues, providing data on principles as well as working procedures for the diagnosis and treatment of patients with ESLD complicated by infections.